Seroquel - Biotech, Pharma and Life Science Channel
Seroquel, an atypical antipsychotic medication has annual sales of $3.1m (in 2009), and based on annual sales, ranks 5th in the world. It is produced by AstraZeneca Pharmaceuticals as a quetiapine fumarate.
It is recommended for bipolar disorder (in cases of acute depression or mixed episodes), schizophrenia and depression, and can be used long-term, both in adolescents and adults.
Source; Adapted from BioPortfolio.com and Seroquel.com
Add the Seroquel News Channel to your RSS reader;
Follow the Seroquel Twitter feed;
News Articles
Presented at the 166th American Psychiatric Association Annual Meeting in San Francisco Sunovion Pharmaceuticals Inc. today announced results from a post-hoc study anal...
AstraZeneca results - The Economist Intelligence Unit
"Shareholders at AstraZeneca are getting restive. The company has long known that patent expiries, notably for anti-psychotic Seroquel, were going to eat into revenues, but it has so far failed...
MALVERN, Pa., March 6, 2013 /PRNewswire/ -- Michael Hickey, former Vice President of US Sales at AstraZeneca and former President of AstraZeneca, Netherlands has recently joined Delta Point, Inc....
AtheroNova Names New Clinical Affairs Officer
IRVINE, Calif., Jan. 8, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and imp...
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Seroquel XR® in the U.S.
WOODCLIFF LAKE, N.J., Oct. 29, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition...
Most Read Pharmaceutical and Health Condition News - September '12
AUSTIN, Texas, Oct. 3, 2012 /PRNewswire/ -- dailyRx, Inc., a leading digital news publisher, announced today the top five health conditions and medications viewed on the dailyRx News Network...
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that significant opportunity remains in the unipolar d...
Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
NEW YORK, Aug. 21, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released second quarter 2012 U.S. prescription sales data for the top 100 drugs. Proton-pump i...
Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds through examination of U.S. patient-level clai...
Intellipharmaceutics Settles Patent Litigation With AstraZeneca Concerning Generic Seroquel XR(R)
TORONTO, July 31, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel a...
Events
None
Companies
None
Clinical Trials
The purpose of this study is to determine that the efficacy of the sustained release (SR) formulation of quetiapine (Seroquel) is not inferior to the immediate release (IR) formulation....
The purpose of this 6-week study is to determine whether treatment with Seroquel® Sustained Release (SR) is more effective than placebo in the treatment of acute schizophrenia. PLEASE NO...
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
Objective: The objective of this study is to quantitatively examine the efficacy of Seroquel (active ingredient quetiapine fumarate) in subjects with Borderline Personality Disorder (BPD)...
Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar...
Antipsychotic Polypharmacy in Schizophrenia
The literature suggests that when a patient is prescribed more than one antipsychotic for at least 30 days, he or she is likely to continue on that combination. In this 12 week study 100 a...
Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk therapy) for the treatment of bipolar II depression. The name of this psychotherapy is Interpe...
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
The primary purpose of this study is to evaluate whether treatment with (SEROQUEL SR) quetiapine fumarate sustained release (SR) for 9 weeks compared to placebo will improve elderly patien...
To evaluate the efficacy of quetiapine fumarate sustained release (Seroquel SR™) in combination with an antidepressant versus an antidepressant alone in patients with Major Depressive Di...
To evaluate the efficacy and safety of quetiapine fumarate sustained release (Seroquel SR) in the treatment of Major Depressive Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer...
The purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder. PLEASE NOTE: Ser...
PubMed Articles
Abstract Objective: To evaluate the efficacy and safety of 750 mg/day quetiapine fumarate (Seroquel * ) in the treatment of Chinese Han patients with schizophrenia. Methods: In this 6-week, multicente...
Videos
Seroquel (Quitiapine) - A Review
A review of Seroquel (Quitiapine) in the treatment of bipolar disorder.
